10 Einträge |
Seite 1 / 1
![]() |
Efficacy of RG1-VLP vaccination against infections with genital and cutaneous human papillomaviruses. |
Schellenbacher C, Kwak K, Fink D, Shafti-Keramat S, Huber B, Jindra C, Faust H, Dillner J, Roden RB, Kirnbauer R |
The Journal of investigative dermatology. 2013 May 10. pii: jid2013253. doi: 10.1038/jid.2013.253. pmc: PMC3826974. mid: EMS54966 |
PMID: 23752042 |
A quadrivalent HPV vaccine induces humoral and cellular immune responses in WHIM immunodeficiency syndrome. |
Handisurya A, Schellenbacher C, Reininger B, Koszik F, Vyhnanek P, Heitger A, Kirnbauer R, Förster-Waldl E |
Vaccine. 2010 May 14. pii: S0264-410X(10)00581-5. doi: 10.1016/j.vaccine.2010.04.057. pmc: PMC3792336. mid: EMS54982 |
PMID: 20472031 |
Bovine papillomavirus type 1 (BPV1) and BPV2 are closely related serotypes. |
Shafti-Keramat S, Schellenbacher C, Handisurya A, Christensen N, Reininger B, Brandt S, Kirnbauer R |
Virology. 2009 Sep 3. pii: S0042-6822(09)00474-7. doi: 10.1016/j.virol.2009.07.036. pmc: PMC3792341. mid: EMS54975 |
PMID: 19729180 |
Chimeric L1-L2 virus-like particles as potential broad-spectrum human papillomavirus vaccines. |
Schellenbacher C, Roden R, Kirnbauer R |
Journal of virology. 2009 Jul 29. pii: JVI.01088-09. doi: 10.1128/JVI.01088-09. pmc: PMC2748020 |
PMID: 19640991 |
Rapid progression of an anal Buschke-Lowenstein tumour into a metastasising squamous cell carcinoma in an HIV-infected patient. |
Handisurya A, Rieger A, Bago-Horvath Z, Schellenbacher C, Bankier A, Salat A, Stingl G, Kirnbauer R |
Sexually transmitted infections. 2009 Jul 23. pii: 85/4/261. doi: 10.1136/sti.2008.034959. pmc: PMC3935459. mid: EMS55135 |
PMID: 19625295 |
A papillomavirus-like particle (VLP) vaccine displaying HPV16 L2 epitopes induces cross-neutralizing antibodies to HPV11. |
Slupetzky K, Gambhira R, Culp TD, Shafti-Keramat S, Schellenbacher C, Christensen ND, Roden RB, Kirnbauer R |
Vaccine. 2006 Nov 29. pii: S0264-410X(06)01255-2. doi: 10.1016/j.vaccine.2006.11.049. pmc: PMC3935451. mid: EMS54968 |
PMID: 17239496 |
Establishment of an in vitro equine papillomavirus type 2 (EcPV2) neutralization assay and a VLP-based vaccine for protection of equids against EcPV2-associated genital tumors. |
Schellenbacher C, Shafti-Keramat S, Huber B, Fink D, Brandt S, Kirnbauer R |
Virology. 2015 Oct 28. pii: S0042-6822(15)00373-6. doi: 10.1016/j.virol.2015.08.016 |
PMID: 26519597 |
Human papillomavirus vaccination induces neutralising antibodies in oral mucosal fluids. |
Handisurya A, Schellenbacher C, Haitel A, Senger T, Kirnbauer R |
British journal of cancer. 2016 Feb 11. pii: bjc2015462. doi: 10.1038/bjc.2015.462 |
PMID: 26867163 |
Developments in L2-based Human Papillomavirus (HPV) Vaccines. |
Schellenbacher C, Roden RB, Kirnbauer R |
Virus research. 2016 Nov 23. pii: S0168-1702(16)30528-7. doi: 10.1016/j.virusres.2016.11.020 |
PMID: 27889616 |
Chimeric L2-Based Virus-Like Particle (VLP) Vaccines Targeting Cutaneous Human Papillomaviruses (HPV). |
Huber B, Schellenbacher C, Shafti-Keramat S, Jindra C, Christensen N, Kirnbauer R |
PloS one. 2017 Jan 5. doi: 10.1371/journal.pone.0169533. pii: PONE-D-16-41348 |
PMID: 28056100 |
10 Einträge |
Seite 1 / 1
![]() |